Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury
- PMID: 27194298
- DOI: 10.1007/s12035-016-9910-6
Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury
Abstract
The blood-spinal cord barrier (BSCB) is a specialized protective barrier that regulates the movement of molecules between blood vessels and the spinal cord parenchyma. Analogous to the blood-brain barrier (BBB), the BSCB plays a crucial role in maintaining the homeostasis and internal environmental stability of the central nervous system (CNS). After spinal cord injury (SCI), BSCB disruption leads to inflammatory cell invasion such as neutrophils and macrophages, contributing to permanent neurological disability. In this review, we focus on the major proteins mediating the BSCB disruption or BSCB repair after SCI. This review is composed of three parts. Section 1. SCI and the BSCB of the review describes critical events involved in the pathophysiology of SCI and their correlation with BSCB integrity/disruption. Section 2. Major proteins involved in BSCB disruption in SCI focuses on the actions of matrix metalloproteinases (MMPs), tumor necrosis factor alpha (TNF-α), heme oxygenase-1 (HO-1), angiopoietins (Angs), bradykinin, nitric oxide (NO), and endothelins (ETs) in BSCB disruption and repair. Section 3. Therapeutic approaches discusses the major therapeutic compounds utilized to date for the prevention of BSCB disruption in animal model of SCI through modulation of several proteins.
Keywords: Angiopoietins; Blood-spinal cord barrier; Bradykinin; HO-1; Matrix metalloproteinase; Spinal cord injury; TNF-α.
Similar articles
-
Matrix metalloproteinase-3 promotes early blood-spinal cord barrier disruption and hemorrhage and impairs long-term neurological recovery after spinal cord injury.Am J Pathol. 2014 Nov;184(11):2985-3000. doi: 10.1016/j.ajpath.2014.07.016. Epub 2014 Oct 14. Am J Pathol. 2014. PMID: 25325922
-
Epidermal growth factor attenuates blood-spinal cord barrier disruption via PI3K/Akt/Rac1 pathway after acute spinal cord injury.J Cell Mol Med. 2016 Jun;20(6):1062-75. doi: 10.1111/jcmm.12761. Epub 2016 Jan 15. J Cell Mol Med. 2016. PMID: 26769343 Free PMC article.
-
Metformin ameliorates BSCB disruption by inhibiting neutrophil infiltration and MMP-9 expression but not direct TJ proteins expression regulation.J Cell Mol Med. 2017 Dec;21(12):3322-3336. doi: 10.1111/jcmm.13235. Epub 2017 Jul 12. J Cell Mol Med. 2017. PMID: 28699677 Free PMC article.
-
Blood-Spinal Cord Barrier in Spinal Cord Injury: A Review.J Neurotrauma. 2021 May 1;38(9):1203-1224. doi: 10.1089/neu.2020.7413. Epub 2021 Feb 16. J Neurotrauma. 2021. PMID: 33292072 Review.
-
The blood-spinal cord barrier: morphology and clinical implications.Ann Neurol. 2011 Aug;70(2):194-206. doi: 10.1002/ana.22421. Epub 2011 Jun 14. Ann Neurol. 2011. PMID: 21674586 Review.
Cited by
-
5-hydroxytryptamine 1F Receptor Agonist Induces Mitochondrial Biogenesis and Promotes Recovery from Spinal Cord Injury.J Pharmacol Exp Ther. 2020 Feb;372(2):216-223. doi: 10.1124/jpet.119.262410. Epub 2019 Nov 27. J Pharmacol Exp Ther. 2020. PMID: 31776207 Free PMC article.
-
Matrix metalloproteinase signals following neurotrauma are right on cue.Cell Mol Life Sci. 2019 Aug;76(16):3141-3156. doi: 10.1007/s00018-019-03176-4. Epub 2019 Jun 6. Cell Mol Life Sci. 2019. PMID: 31168660 Free PMC article. Review.
-
Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-κB pathway dependent of HDAC3.J Neuroinflammation. 2018 May 18;15(1):150. doi: 10.1186/s12974-018-1193-6. J Neuroinflammation. 2018. PMID: 29776446 Free PMC article.
-
Intravenous administration exosomes derived from human amniotic mesenchymal stem cells improves neurological recovery after acute traumatic spinal cord injury in rats.Iran J Basic Med Sci. 2024;27(10):1284-1292. doi: 10.22038/ijbms.2024.76532.16576. Iran J Basic Med Sci. 2024. PMID: 39229573 Free PMC article.
-
Vagus Nerve Stimulation Prevents Endothelial Necroptosis to Alleviate Blood-Spinal Cord Barrier Disruption After Spinal Cord Injury.Mol Neurobiol. 2023 Nov;60(11):6466-6475. doi: 10.1007/s12035-023-03477-7. Epub 2023 Jul 17. Mol Neurobiol. 2023. PMID: 37460917
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical